Home/Filings/4/0001415889-23-000766
4//SEC Filing

JORDAN ANDREW R 4

Accession 0001415889-23-000766

CIK 0000861838other

Filed

Jan 9, 7:00 PM ET

Accepted

Jan 10, 9:19 PM ET

Size

6.7 KB

Accession

0001415889-23-000766

Insider Transaction Report

Form 4
Period: 2023-01-06
JORDAN ANDREW R
Chief Strategy Officer
Transactions
  • Award

    Common Stock

    2023-01-06+261,718913,082 total
  • Tax Payment

    Common Stock

    2023-01-06$0.71/sh73,940$52,490839,142 total
Footnotes (2)
  • [F1]Represents shares of common stock granted under the Idera Pharmaceuticals, Inc. 2013 Stock Incentive Plan, as amended and restated. The shares were granted pursuant to that certain Employment Continuation and Retention Bonus Letter Agreement, dated as of September 28, 2022, between the Issuer and Reporting Person.
  • [F2]Represents the number of shares withheld by Issuer to cover tax obligations in connection with the grant of the shares of common stock.

Issuer

IDERA PHARMACEUTICALS, INC.

CIK 0000861838

Entity typeother

Related Parties

1
  • filerCIK 0001206350

Filing Metadata

Form type
4
Filed
Jan 9, 7:00 PM ET
Accepted
Jan 10, 9:19 PM ET
Size
6.7 KB